Regulatory and Legal Challenges The evolving regulatory landscape creates ongoing challenges for healthcare providers and patients
RECIST responses were seen in 2/7 patients with measurable soft tissue disease 79
Individual experiences vary widely, and some people find the effects ease once they settle on a steady dose
Relative contraindications may include significant cancer risk factors, bleeding disorders, and concurrent use of anticoagulant medications
These could signal something beyond typical adjustment effects
When purified protein was incubated with the gels (Figure 2), a significant decrease in GST-GFP was found in the solution after two hours compared to gel-free controls in the 1:1 (p = 0.008), 5:1 (p = 0.005), 20:1 (p = 0.02), 40:1 (p = 0.02), and 80:1 (p = 0.02) PEGDA to glutathione ratio gels (Figure 2A)